Mohamad Makhzoumi is > 10% Shareholder of AVEO PHARMACEUTICALS, INC.. Currently has a direct ownership of 559 shares of AVEO, which is worth approximately $0. The most recent transaction as insider was on Oct 19, 2022, when has been sold 559 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 559
0% 3M change
0% 12M change
Total Value Held $0

Mohamad Makhzoumi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2022
BUY
Other acquisition or disposition
-
559 Added 50.0%
559 Common Stock

Also insider at

EAR
Eargo, Inc. Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
DM
Desktop Metal, Inc. Technology
BHG
Bright Health Group Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
HOOD
Robinhood Markets, Inc. Technology
TRVI
Trevi Therapeutics, Inc. Healthcare
MTCR
Metacrine, Inc. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
IONQ
IonQ, Inc. Technology
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
MM

Mohamad Makhzoumi

> 10% Shareholder
Menlo Park, CA

Track Institutional and Insider Activities on AVEO

Follow AVEO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVEO shares.

Notify only if

Insider Trading

Get notified when an Aveo Pharmaceuticals, Inc. insider buys or sells AVEO shares.

Notify only if

News

Receive news related to AVEO PHARMACEUTICALS, INC.

Track Activities on AVEO